UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056627
Receipt number R000064720
Scientific Title Glucose Insight in Pregnancy Study
Date of disclosure of the study information 2025/01/06
Last modified on 2026/01/05 22:37:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Glucose Insight in Pregnancy Study

Acronym

GIP study

Scientific Title

Glucose Insight in Pregnancy Study

Scientific Title:Acronym

GIP study

Region

Japan


Condition

Condition

pregnant women

Classification by specialty

Endocrinology and Metabolism Obstetrics and Gynecology Pediatrics
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evidence building for constructing blood glucose management goals for pregnancy and labor in pregnancies complicated by abnormal glucose metabolism

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Investigation of blood glucose variability during the entire gestational and parturient period in pregnant women with normal glucose tolerance and those with abnormal glucose metabolism

Key secondary outcomes

1) To examine the association between glycemic variables during the entire gestational and parturient periods and perinatal complications in pregnant women with abnormal glucose metabolism
2) Obtain the latest and best evidence on the association between blood glucose changes during the entire pregnancy and delivery period, abnormal glucose metabolism, and perinatal complications in all pregnant women through a systematic review


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

Normal glucose tolerance pregnant women (NGT) and pregnant women with diabetes in pregnancy (DIP)

Key exclusion criteria

1) Those with other comorbidities (cardiac disease, collagen disease, blood disease, psychiatric disease, etc.)
2) Those who have had severe symptoms such as contact dermatitis caused by adhesive plasters or medical tapes in the past

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Marie
Middle name
Last name FURUTA

Organization

Department of Human Health Sciences, Graduate School of Medicine, Kyoto University

Division name

perinatal epidemiology

Zip code

606-8507

Address

53 Kawahara-cho Shogo-in, Sakyo-ku, Kyoto

TEL

075-751-3972

Email

harashima.shinichi.38m@st.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Shinichi
Middle name
Last name HARASHIMA

Organization

Department of Human Health Sciences, Graduate School of Medicine, Kyoto University

Division name

perinatal epidemiology

Zip code

606-8507

Address

53 Kawahara-cho Shogo-in, Sakyo-ku, Kyoto

TEL

075-751-3972

Homepage URL


Email

harashima.shinichi.38m@st.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

450

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 06 Month 30 Day

Date of IRB

2019 Year 07 Month 18 Day

Anticipated trial start date

2019 Year 07 Month 18 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The purpose of this study is to build credible evidence regarding Diabetes in Pregnancy (DIP) gestational and peripartum glycemic control goals to be used in the development of practice guidelines. To this end, we aim to achieve each of the following objectives, with the ultimate goal of.
(1) To evaluate glycemic variability during all gestational and parturient periods in Normal Glucose Tolerance (NGT) as well as DIP pregnant women using continous glucose monitoring (CGM).
(2) To examine the association between perinatal complications and blood glucose variability during the entire gestational and parturitional phases in DIP pregnant women.
(3) Obtain the latest and best evidence on the association between glycemic variability, abnormal glucose metabolism, and perinatal complications during all gestational and parturient periods in all pregnant women through a systematic review.


Management information

Registered date

2025 Year 01 Month 04 Day

Last modified on

2026 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064720